Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 27:16:e24.
doi: 10.15420/icr.2020.28. eCollection 2021 Apr.

Functionally Complete Coronary Revascularisation in Patients Presenting with ST-elevation MI and Multivessel Coronary Artery Disease

Luigi Di Serafino  1 , Fabio Magliulo  1 , Giovanni Esposito  1
Affiliations
Review

Functionally Complete Coronary Revascularisation in Patients Presenting with ST-elevation MI and Multivessel Coronary Artery Disease

Luigi Di Serafino et al. Interv Cardiol. .

Abstract

Up to half of patients undergoing primary percutaneous coronary intervention of a culprit stenosis in the context of the ST-elevation MI may present with multivessel disease. The presence of non-culprit stenoses have been shown to affect the outcomes of these patients, and the results of the more recent randomised trials highlight the importance of complete coronary revascularisation. In this paper, the authors review the main trials published on the topic and discuss tools for the assessment of non-culprit stenoses, while considering the right time for carrying out a complete coronary revascularisation.

Keywords: ST-elevation MI; complete revascularisation; fractional flow reserve; non-culprit stenosis; quantitative flow ratio.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflicts of interest to declare.

Figures

Figure 1:
Figure 1:. Stenosis After Percutaneous Coronary Intervention
Figure 2:
Figure 2:. Angiographic and Functional Evaluation of a Right Coronary Artery Stenosis
See this image and copyright information in PMC

References

    1. Sorajja P, Gersh BJ, Cox DA et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J. 2007;28:1709–16. doi: 10.1093/eurheartj/ehm184. - DOI - PubMed
    1. van der Schaaf RJ, Timmer JR, Ottervanger JP et al. Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy. Heart. 2006;92:1760–63. doi: 10.1136/hrt.2005.086058. - DOI - PMC - PubMed
    1. Wald DS, Morris JK, Wald NJ et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med. 2013;369:1115–23. doi: 10.1056/NEJMoa1305520. - DOI - PubMed
    1. Gershlick AH, Khan JN, Kelly DJ et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2015;65:963–72. doi: 10.1016/j.jacc.2014.12.038. - DOI - PMC - PubMed
    1. Engstrøm T,, Kelbæk H,, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015;386:665–71. doi: 10.1016/S0140-6736(15)60648-1. - DOI - PubMed

LinkOut - more resources